Ashton Thomas Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ashton Thomas Securities’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.43K	Hold	44	–	–	﹤0.01%	491
2026 Q2	$5.21K	Sell	44 -11	-20%	-$1.19K	﹤0.01%	369
2026 Q1	$5.71K	Hold	55	–	–	﹤0.01%	427
2025 Q4	$5.75K	Hold	55	–	–	﹤0.01%	289
2025 Q3	$5.09K	Hold	55	–	–	﹤0.01%	386
2025 Q2	$4.39K	Hold	55	–	–	﹤0.01%	274
2025 Q1	$4.76K	Hold	55	–	–	﹤0.01%	254
2024 Q4	$4.54K	Hold	55	–	–	﹤0.01%	251
2024 Q3	$4.78K	Buy	+55	New	+$4.71K	﹤0.01%	950

Other funds holding PJP

Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return

Dumont & Blake Investment Advisors Princeton, New Jersey $398M AUM 22.72% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Diversified Enterprises Wilmington, Delaware $2.16B AUM 14.54% 1-Year Est. Return

Simon Quick Advisors Morristown, New Jersey $2.63B AUM 14.45% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Ashton Thomas Securities's PJP Position: Q3 2026 in Review

Ashton Thomas Securities held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 44 shares worth $5.43K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

Ashton Thomas Securities first reported a position in PJP in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.75K in Q4 2025. 28 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Ashton Thomas Securities held 44 shares of Invesco Pharmaceuticals ETF worth $5.43K as of Q3 2026.
Ashton Thomas Securities left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Ashton Thomas Securities's portfolio in Q3 2026, its #491 holding.
Ashton Thomas Securities first reported a position in Invesco Pharmaceuticals ETF in Q3 2024 and has held it in 9 quarters since.
Ashton Thomas Securities's Invesco Pharmaceuticals ETF position peaked at $5.75K in Q4 2025.
28 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Ashton Thomas Securities's 13F filing for Q3 2026, filed 26 Oct 2026.